Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Comparison of the Effectiveness of Two Different Methods in Reducing Pain and Anxiety

23 de maio de 2026 atualizado por: Celal Bayar University

Comparison of the Effectiveness of Two Different Methods in Reducing Pain and Anxiety During Blood Collection: Breathing Exercises and Stress Ball

Aim: This study was conducted to determine the effect of distraction techniques (breathing exercises and stress ball squeezing) applied to adults during blood collection on pain and anxiety. Materials and Methods: The sample consisted of 90 patients who applied for admission to the Physical Therapy and Rehabilitation Department of Turgutlu State Hospital between March 2025 and February 2026, comprising 30 breathing exercise, 30 stress ball, and 30 control groups. Data collection utilised the 'Demographic Characteristics Form', the 'State Anxiety Scale' and the 'Visual Anxiety Scale', the 'Visual Pain Scale'the 'Life Findings Form' to record life and the 'Informed Consent Form' were used . Descriptive statistical methods (number, percentage, median, mean, standard deviation), chi-square, Kolmogorov-Smirnov, Kruskal- Wallis, Wilcoxon, Bonferroni and Friedman were used when evaluating the data.

Visão geral do estudo

Status

Concluído

Condições

Descrição detalhada

Inclusion Criteria for the Study Individuals who are 18-65 years of age, have no verbal, perceptual, or visual communication problems, have person-place-time orientation, have an average pressure pain threshold of 8-16 pounds (Lb), have not used any medication that would produce an analgesic effect in the last 6 hours before blood sampling, do not have chronic or acute pain, do not have a disease that would impair their ability to feel pain (such as neuropathy), are on their first day of hospitalization, and are willing to participate in the study were included.

Exclusion Criteria Individuals who cannot have IV procedures performed on their forearm veins, have a diagnosis of stroke from cerebrovascular diseases (CVD), cannot actively use their hands (hemiplegia, fracture, fistula, etc.), have respiratory tract disease, have a condition that prevents them from performing breathing exercises, and have never had blood drawn before were not included in the study.

Tipo de estudo

Intervencional

Inscrição (Real)

90

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Yunusemre
      • Manisa, Yunusemre, Turquia (Türkiye), 45140
        • Kıvan ÇEVİK KAYA

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Individuals with no communication difficulties in terms of verbal, sensory, or visual aspects,
  • who are oriented to person, time, and place,
  • with an average pressure pain threshold of 8-16 pounds (lb),
  • who have not taken any medication that would produce an analgesic effect within the
  • last 6 hours prior to the blood draw,
  • who do not have chronic or acute pain,
  • who do not have a condition that would impair their ability to feel pain (such as neuropathy),
  • who are on the first day of their hospital admission,
  • who are willing to participate in the study

Exclusion Criteria:

  • Individuals who cannot undergo IV procedures in their forearm veins,
  • who have been diagnosed with stroke due to cerebrovascular disease (CVD),
  • who cannot actively use their hands (e.g., due to hemiplegia, fractures, or fistulas) for the breathing exercises group;
  • individuals with respiratory diseases,
  • those with conditions preventing them from performing breathing exercises,
  • individuals who have never had blood drawn before

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Sem intervenção: Ao controle
Sem intervenção
Experimental: Stress ball
Stress balls were provided to the individuals in this group during routine venous blood draws.
The stress ball, made of soft plastic and designed to be held comfortably in the hand, can be squeezed and released to return to its original shape; it measures 8-10 cm in diameter and has a smooth surface. The stress ball was given to the participant's hand on the side opposite the blood draw site, and they were instructed to squeeze and release it throughout the procedure. A separate stress ball was used for each participant. Information was provided about the Visual Analog Scale (VAS) to be used to measure pain levels during the blood draw, and the researcher asked about pain levels and anxiety levels during the procedure. After the blood draw was completed, participants were asked to complete the Vital Signs Form, the State Anxiety Scale, the Visual Anxiety Scale, and the Visual Pain Scale again.
Experimental: Breathing exercise
Breathing exercises were started before the blood draw began, and participants continued the breathing exercises during the blood draw; the breathing exercises were concluded at the end of the procedure.
After individuals were taught breathing exercises, they were asked to begin the breathing exercises before the blood draw began. The individuals continued the breathing exercises during the blood draw, and the breathing exercises were stopped at the end of the procedure. Information was provided regarding the VAS to be used to measure pain levels during the blood draw, and the researcher asked about pain levels and anxiety levels during the procedure. After the blood draw was completed, participants were asked to complete the Vital Signs Form, the State Anxiety Scale, the Visual Anxiety Scale, and the Visual Pain Scale again.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Anxiety
Prazo: day 1
Anxiety of patient was assessed with State Anxiety Scale. The scale consists of 20 items and is a 4-point Likert-type scale (1 = "not at all," 2 = "somewhat," 3 = "very," 4 = "completely"). The individual is asked to assess how they feel "right now" and select the appropriate response based on the intensity of the emotions or behaviors described in the items. The total score on the State Anxiety Scale ranges from 20 to 80. The score categories are as follows: 0-19 points: no anxiety; 20-39 points: mild anxiety; 40-59 points: moderate anxiety; 60-79 points: severe anxiety; 80 points: panic. Items 1, 2, 5, 8, 10, 11, 15, 16, 19, and 20 on the scale are reversed and used in the scoring. Higher scores indicate a higher level of anxiety, while lower scores indicate a lower level of anxiety. As scores increase, the level of anxiety also rises.
day 1
Acute Pain
Prazo: day 1
Pain of patient was assessed with Visual Analogue Scale. The Visual Analogue Scale (VAS) may be preferred as an alternative to the Numerical Rating Scale. It is a 10-cm-long vertical or horizontal line with "No pain" written at one end and "Unbearable pain" at the other, used to measure the intensity of acute pain.
day 1

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
blood pressure
Prazo: Day 1
Physiologically, pain can lead to tachycardia, increased cardiac output, improved myocardial oxygenation, hypoxia, reduced lung ventilation, nausea, vomiting, and other such issues; psychologically, it can result in increased anxiety and stress levels, behavioral disorders, and sleep problems. This form was developed to record vital signs-including pulse, blood pressure, and oxygen saturation-measured in patients both before and immediately after the procedure.
Day 1
Pulse
Prazo: Day 1
Physiologically, pain can lead to tachycardia, increased cardiac output, improved myocardial oxygenation, hypoxia, reduced lung ventilation, nausea, vomiting, and other such issues; psychologically, it can result in increased anxiety and stress levels, behavioral disorders, and sleep problems. This form was developed to record vital signs-including pulse, blood pressure, and oxygen saturation-measured in patients both before and immediately after the procedure.
Day 1
oxygen saturation
Prazo: Day 1
Physiologically, pain can lead to tachycardia, increased cardiac output, improved myocardial oxygenation, hypoxia, reduced lung ventilation, nausea, vomiting, and other such issues; psychologically, it can result in increased anxiety and stress levels, behavioral disorders, and sleep problems. This form was developed to record vital signs-including pulse, blood pressure, and oxygen saturation-measured in patients both before and immediately after the procedure.
Day 1

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de março de 2025

Conclusão Primária (Real)

30 de março de 2025

Conclusão do estudo (Real)

28 de fevereiro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

23 de março de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

23 de maio de 2026

Primeira postagem (Real)

1 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

1 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

23 de maio de 2026

Última verificação

1 de maio de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever